ANAPTYSBIO, INC (ANAB) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US0327241065
ANAPTYSBIO, INC financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 234.60 m USD |
| Operating income | 47.90 m USD |
| EBIT | -13.07 m USD |
| Net income | -13.23 m USD |
| Diluted EPS – continuing operations | -0.46 USD |
Full history since 2013, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About ANAPTYSBIO, INC
AnaptysBio, Inc., a clinical-stage biotechnology company, focuses in delivering immunology therapeutics for autoimmune and inflammatory diseases in the United States. The company's products include Rosnilimab, a selective pathogenic T cell deplete which completed a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis; ANB033, a CD122 antagonist, which is in a Phase 1b trial for celiac disease and eosinophilic esophagitis; ANB101, a BDCA2 modulator antibody which is in Phase 1a trial that specifically targets plasmacytoid dendritic cells and inhibits interferon secretion and modulates antigen presentation; dostarlimab, a PD-1 antagonist for various solid tumor indications; and Imsidolimab, an antibody that inhibits the interleukin-36 receptor, which is in the Phase 3 development for the treatment of generalized pustular psoriasis. It focuses on developing various antibody programs that are advanced to preclinical and clinical milestones under its collaborations. It has collaborations agreement with GSK and Vanda. The company was formerly known as Anaptys Biosciences, Inc. and changed its name to AnaptysBio, Inc. in July 2006. AnaptysBio, Inc. was incorporated in 2005 and is based in San Diego, California.
More stocks
- StarHub Ltd (CC3.SI)
- NABORS INDUSTRIES LTD (NBR)
- Linea Directa Aseguradora SA Compania de Seguros y Reaseguros (LDA.MC)
- Scientech Corp (3583.TW)
- Chongqing Baiya Sanitary Products Co (003006.SZ)
- Cembre SpA (CMB.MI)
- Grupo Mateus S.A (GMAT3.SA)
- Modern Times Group MTG AB (MTG B.ST)
- Henan Zhongyuan Expressway Co Ltd (600020.SS)
- MONY Group PLC (MONY.L)
- GCH Technology Co. Ltd. A (688625.SS)
- Atresmedia Corporacion de Medios de Comunicacion SA (A3M.MC)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.